Mubadala Bio Launches to Bolster UAE Drug Security

Mubadala Bio launches to bolster UAE drug security

Mubadala Bio to oversee 10 facilities UAE pharma imports worth $6bn Aiming for self-sufficiency Mubadala Investment Company, Abu Dhabi’s $330 billion sovereign wealth fund, has launched a dedicated life sciences unit as part of a broader strategy to boost domestic pharmaceutical production, improve healthcare resilience and support the UAE’s economic diversification efforts. The new entity, Mubadala Bio, will oversee a portfolio of 10 manufactur…

Mubadala Launches Mubadala Bio to Strengthen UAE's Pharmaceutical Industry

Prime Highlights : Mubadala launches Mubadala Bio to create UAE’s pharma manufacturing and healthcare capability. It operates 10 sites worldwide, producing more than 2.5 billion tablets and 120 million injectables annually. Key Facts : Mubadala Bio supplies to more than 100 countries, covering a portfolio of more than 10,000 products across key therapeutic classes. It has six UAE sites, covering a total area of more than 110,000 sqm. Key Backgro…